论文部分内容阅读
目的观察美托洛尔治疗扩张型心肌病的临床疗效。方法 100例扩张型心肌病患者,随机分为观察组与对照组,各50例。对照组采用常规治疗方法 ,观察组则在对照组基础上加用美托洛尔治疗。对比分析两组治疗效果。结果观察组总有效率为96.00%,明显高于对照组的64.00%,差异有统计学意义(P<0.05)。治疗后,两组6 min步行测试结果较治疗前均有显著改善,差异均有统计学意义(P<0.05);且观察组较对照组改善情况更显著,差异有统计学意义(P<0.05)。结论对于扩张型心肌病患者采用美托洛尔治疗有显著的临床效果,有效地改善了患者的心功能情况,提高了患者的生活质量,值得在临床上推广应用。
Objective To observe the clinical efficacy of metoprolol in the treatment of dilated cardiomyopathy. Methods 100 patients with dilated cardiomyopathy were randomly divided into observation group and control group, 50 cases each. The control group with conventional treatment, the observation group is based on the control group plus metoprolol treatment. Comparative analysis of two groups of treatment. Results The total effective rate in observation group was 96.00%, which was significantly higher than that in control group (64.00%), the difference was statistically significant (P <0.05). After treatment, the results of 6-minute walk test in both groups were significantly improved compared with those before treatment (all P <0.05), and the improvement in the observation group was more significant than that in the control group (P <0.05 ). Conclusions Metoprolol treatment for patients with dilated cardiomyopathy has significant clinical effect, effectively improving the patient’s cardiac function and improving the quality of life of patients, which is worth popularizing and applying in clinic.